Defective Mitochondrial Fatty Acid Oxidation and Lipotoxicity in Kidney Diseases

被引：112

作者：

Jang, Hee-Seong ^{[1
]}

Noh, Mi Ra ^{[1
]}

Kim, Jinu ^{[1
,2
,3
]}

Padanilam, Babu J. ^{[1
,4
]}

机构：

[1] Univ Nebraska, Med Ctr, Dept Cellular & Integrat Physiol, Omaha, NE 68182 USA

[2] Jeju Natl Univ, Sch Med, Dept Anat, Jeju, South Korea

[3] Jeju Natl Univ, Interdisciplinary Grad Program Adv Convergence Te, Jeju, South Korea

[4] Univ Nebraska, Med Ctr, Sect Nephrol, Internal Med, Omaha, NE 68182 USA

来源：

FRONTIERS IN MEDICINE | 2020年 / 7卷

基金：

新加坡国家研究基金会;

关键词：

mitochondria; fatty acid beta-oxidation; lipotoxicity; acute kidney injury; chronic kidney disease; diabetic nephropathy; polycystic kidney disease; glomerular nephropathy; PPAR-ALPHA AGONIST; NF-KAPPA-B; POLYCYSTIC KIDNEY; BETA-OXIDATION; LIPID NEPHROTOXICITY; ENERGY-METABOLISM; PROXIMAL TUBULES; FENOFIBRATE; ACCUMULATION; PROTECTS;

D O I：

10.3389/fmed.2020.00065

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The kidney is a highly metabolic organ and uses high levels of ATP to maintain electrolyte and acid-base homeostasis and reabsorb nutrients. Energy depletion is a critical factor in development and progression of various kidney diseases including acute kidney injury (AKI), chronic kidney disease (CKD), and diabetic and glomerular nephropathy. Mitochondrial fatty acid beta-oxidation (FAO) serves as the preferred source of ATP in the kidney and its dysfunction results in ATP depletion and lipotoxicity to elicit tubular injury and inflammation and subsequent fibrosis progression. This review explores the current state of knowledge on the role of mitochondrial FAO dysfunction in the pathophysiology of kidney diseases including AKI and CKD and prospective views on developing therapeutic interventions based on mitochondrial energy metabolism.

引用

页数：8

共 50 条

[1] Lipotoxicity, fatty acid uncoupling and mitochondrial carrier function
Rial, Eduardo
Rodriguez-Sanchez, Leonor
Gallardo-Vara, Eunate
Zaragoza, Pilar
Moyano, Eva
Mar Gonzalez-Barroso, M.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 2010, 1797 (6-7): : 800 - 806
[2] Biochemical Markers for the Diagnosis of Mitochondrial Fatty Acid Oxidation Diseases
Ruiz-Sala, Pedro
Pena-Quintana, Luis
JOURNAL OF CLINICAL MEDICINE, 2021, 10 (21)
[3] Dysfunctions of mitochondrial fatty acid β-oxidation in rare and common diseases
Bastin, Jean
Djouadi, Fatima
M S-MEDECINE SCIENCES, 2019, 35 (10): : 779 - 786
[4] Impaired fatty acid oxidation as a cause for lipotoxicity in cardiomyocytes
Haffar, T.
Berube-Simard, F.
Bousette, N.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2015, 468 (1-2) : 73 - 78
[5] The Link Between the Mitochondrial Fatty Acid Oxidation Derangement and Kidney Injury
Console, Lara
Scalise, Mariafrancesca
Giangregorio, Nicola
Tonazzi, Annamaria
Barile, Maria
Indiveri, Cesare
FRONTIERS IN PHYSIOLOGY, 2020, 11
[6] Lipotoxicity in Diabetic Nephropathy: The Potential Role of Fatty Acid Oxidation
Murea, Mariana
Freedman, Barry I.
Parks, John S.
Antinozzi, Peter A.
Elbein, Steven C.
Ma, Lijun
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 5 (12): : 2373 - 2379
[7] FLAVOPROTEINS OF MITOCHONDRIAL FATTY ACID OXIDATION
GARLAND, PB
CHANCE, B
ERNSTER, L
LEE, CP
WONG, D
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1967, 58 (04) : 1696 - &
[8] Mitochondrial Fatty Acid Oxidation in Obesity
Serra, Dolors
Mera, Paula
Malandrino, Maria Ida
Mir, Joan Francesc
Herrero, Laura
ANTIOXIDANTS & REDOX SIGNALING, 2013, 19 (03) : 269 - 283
[9] Lipotoxicity, an imbalance between lipogenesis de novo and fatty acid oxidation
Lelliott, C
Vidal-Puig, AJ
INTERNATIONAL JOURNAL OF OBESITY, 2004, 28 (Suppl 4) : S22 - S28
[10] Fatty Acid β-Oxidation in Kidney Diseases: Perspectives on Pathophysiological Mechanisms and Therapeutic Opportunities
Gao, Zhumei
Chen, Xiangmei
FRONTIERS IN PHARMACOLOGY, 2022, 13

← 1 2 3 4 5 →